Blood-based biomarker in Parkinson’s disease: potential for future applications in clinical research and practice

The clinical presentation of Parkinson’s disease (PD) is both complex and heterogeneous, and its precise classification often requires an intensive work-up. The differential diagnosis, assessment of disease progression, evaluation of therapeutic responses, or identification of PD subtypes frequently...

Descripción completa

Detalles Bibliográficos
Autores principales: Tönges, Lars, Buhmann, Carsten, Klebe, Stephan, Klucken, Jochen, Kwon, Eun Hae, Müller, Thomas, Pedrosa, David J., Schröter, Nils, Riederer, Peter, Lingor, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Neurology and Preclinical Neurological Studies - Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463345/
https://www.ncbi.nlm.nih.gov/pubmed/35428925
http://dx.doi.org/10.1007/s00702-022-02498-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463345/
https://www.ncbi.nlm.nih.gov/pubmed/35428925
http://dx.doi.org/10.1007/s00702-022-02498-1

Ejemplares similares